Virtu Financial’s Achillion Pharmaceuticals ACHN Stock Holding History

Virtu Financial’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$71K	Sell	11,718 -13,573	-54%	-$78.6K	0.01%	1147
2019 Q3	$91K	Buy	25,291 +10,592	+72%	+$40.8K	0.01%	1109
2019 Q2	$39K	Buy	14,699 +3,563	+32%	+$10.5K	﹤0.01%	1279
2019 Q1	$33K	Buy	+11,136	New	+$27.4K	﹤0.01%	1252
2018 Q4	–	Sell	-15,535	Closed	-$57K	–	2182
2018 Q3	$57K	Buy	+15,535	New	+$46.3K	﹤0.01%	1285
2018 Q1	–	Sell	-47,499	Closed	-$137K	–	2939
2017 Q4	$137K	Sell	47,499 -25,304	-35%	-$91.9K	0.01%	1820
2017 Q3	$327K	Buy	+72,803	New	+$323K	0.02%	1306

Other funds holding ACHN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial's ACHN Position: Q4 2019 in Review

Virtu Financial reduced its Achillion Pharmaceuticals (ACHN) stake by 54% in Q4 2019, selling an estimated $78.6K and leaving 11,718 shares worth $71K. The position accounts for 0.01% of the portfolio, ranked #1147.

Virtu Financial first reported a position in ACHN in Q3 2017 and has held it in 7 quarters since. The position peaked at $327K in Q3 2017. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Virtu Financial held 11,718 shares of Achillion Pharmaceuticals worth $71K as of Q4 2019.
Virtu Financial sold 13,573 Achillion Pharmaceuticals shares in Q4 2019, an estimated $78.6K.
Achillion Pharmaceuticals made up 0.01% of Virtu Financial's portfolio in Q4 2019, its #1147 holding.
Virtu Financial first reported a position in Achillion Pharmaceuticals in Q3 2017 and has held it in 7 quarters since.
Virtu Financial's Achillion Pharmaceuticals position peaked at $327K in Q3 2017.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Virtu Financial's 13F filing for Q4 2019, filed 4 Feb 2020.